Medicines Safety Tip: Tresiba Dosing Concerns
Medicines Safety Tip: Tresiba Dosing Concerns
Novo Nordisk is experiencing a shortage of Tresiba® 100units/ml FlexTouch pens, which is expected to last until January 2024. This has resulted in patients being transferred to the 200 units/ml pens and has led to the MHRA and Novo Nordisk issuing a communication regarding safety concerns with dosing when switching between strengths.